United States · FDA National Drug Code directory

Erythromycin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0093-5572_f750327c-00a6-48d0-9a87-b5b0af53a3c3
Product NDC
0093-5572
Form
TABLET, FILM COATED
Composition / generic term
Erythromycin
Labeler
Teva Pharmaceuticals USA, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20210504
Source listing expiry
20261231

Source-listed ingredients

  • ERYTHROMYCIN — 500 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, FILM COATED in 1 BOTTLE (0093-5572-01) · 0093-5572-01
  • 30 TABLET, FILM COATED in 1 BOTTLE (0093-5572-56) · 0093-5572-56

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →